These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1719135)

  • 1. Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
    Nybäck H; Nyman H; Blomqvist G; Sjögren I; Stone-Elander S
    J Neurol Neurosurg Psychiatry; 1991 Aug; 54(8):672-8. PubMed ID: 1719135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H; Nyman H; Schalling D
    Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain glucose metabolism: correlations to biochemical measures and anxiety in patients with schizophrenia.
    Wik G; Wiesel FA
    Psychiatry Res; 1991 Oct; 40(2):101-14. PubMed ID: 1722339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
    Jolkkonen J; Helkala EL; Kutvonen R; Lehtinen M; Riekkinen PJ
    Psychoneuroendocrinology; 1989; 14(1-2):89-95. PubMed ID: 2471986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroups in dementia of the Alzheimer type identified using positron emission tomography.
    Grady CL; Haxby JV; Schapiro MB; Gonzalez-Aviles A; Kumar A; Ball MJ; Heston L; Rapoport SI
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):373-84. PubMed ID: 2136389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase activities and monoamine metabolite levels in the cerebrospinal fluid of patients with Alzheimer's disease.
    Kawakatsu S; Morinobu S; Shinohara M; Totsuka S; Kobashi K
    Biol Psychiatry; 1990 Sep; 28(5):387-400. PubMed ID: 1698467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease.
    Mentis MJ; Weinstein EA; Horwitz B; McIntosh AR; Pietrini P; Alexander GE; Furey M; Murphy DG
    Biol Psychiatry; 1995 Oct; 38(7):438-49. PubMed ID: 8672604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF monoamine metabolites in old age dementias.
    Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
    Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
    Sultzer DL; Mahler ME; Mandelkern MA; Cummings JL; Van Gorp WG; Hinkin CH; Berisford MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(4):476-84. PubMed ID: 8555751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
    Sheline YI; Miller K; Bardgett ME; Csernansky JG
    Am J Geriatr Psychiatry; 1998; 6(2):155-61. PubMed ID: 9581211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
    Freed DM; Corkin S; Growdon JH; Nissen MJ
    Neuropsychologia; 1988; 26(6):895-902. PubMed ID: 2461537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Romani A; Pola A; Zerbi F; Savoldi F
    Eur Arch Psychiatry Neurol Sci; 1989; 239(2):79-86. PubMed ID: 2478368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF; Mohs RC; Davis KL
    Psychiatry Res; 1984 May; 12(1):79-87. PubMed ID: 6205414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites.
    Pomara N; Singh RR; Deptula D; LeWitt PA; Bissette G; Stanley M; Nemeroff CB
    Biol Psychiatry; 1989 Sep; 26(5):500-4. PubMed ID: 2477071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
    Seeldrayers P; Messina D; Desmedt D; Dalesio O; Hildebrand J
    Acta Neurol Scand; 1985 May; 71(5):411-4. PubMed ID: 2409733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional brain metabolism during auditory hallucinations in chronic schizophrenia.
    Cleghorn JM; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman H; Szechtman B; Franco S; Dermer SW; Cook P
    Br J Psychiatry; 1990 Oct; 157():562-70. PubMed ID: 2131139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.